Photodynamic Therapy With Aminolevulinic Acid Topical Solution andVisible Blue Light in the Treatment of Multiple Actinic Keratoses of the Faceand Scalp
Author(s) -
Daniel Piacquadio,
Diana M. Chen,
Harold F. Farber,
Joseph F. Fowler,
Scott D. Glazer,
J. John Goodman,
Luciann L. Hruza,
Edward W. B. Jeffes,
Mark Ling,
Tania J. Phillips,
Tena M. Rallis,
Richard K. Scher,
Charles R. Taylor,
Gerald D. Weinstein
Publication year - 2004
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archderm.140.1.41
Subject(s) - medicine , photodynamic therapy , erythema , dermatology , scalp , actinic keratoses , randomized controlled trial , actinic keratosis , edema , confidence interval , target lesion , lesion , placebo , surgery , pathology , basal cell , chemistry , alternative medicine , organic chemistry , percutaneous coronary intervention , myocardial infarction
To determine the safety and efficacy of photodynamic therapy (PDT) using 20% wt/vol aminolevulinic acid hydrochloride (hereinafter "ALA") and visible blue light for the treatment of multiple actinic keratoses of the face and scalp.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom